US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
StoneCo Ltd (1STNE) 銘柄情報

StoneCo Ltd (1STNE)

0.00

0.00

(0.00%)

終了 6月15日 12:30AM

StoneCo Ltd (1STNE) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

8.356 52 週間の範囲 16.89

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

5,632,013 €

発行済株式数

243,228,226

配当利回り

PER

4.05

1 株当たり利益 (EPS)

13.23

歳入

13.54B

純利益

3.51B

StoneCo Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. The company provides financial services, including payment, prepayment, digital banking, and credit solutions.... StoneCo Ltd. provides financial technology and software solutions to merchants and integrated partners to conduct electronic commerce across in-store, online, and mobile channels in Brazil. The company provides financial services, including payment, prepayment, digital banking, and credit solutions. It offers payment solutions of electronic payments and alternative payment methods, such as payment slips and Pix transactions; digital product to help merchants improve their consumers’ experience, which include split-payment processing, multi-payment processing, and recurring payments for subscriptions; and tap on phone solution. In addition, the company provides prepayment; digital banking; and credit solution. The company serves online, offline, and omni-channel sales clients under Stone, tonstone, and paggar.me. StoneCo Ltd. was founded in 2012 and is based in George Town, the Cayman Islands. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.stoneco.com.br

本社

George Town, Cayman Islands

設立

2026

StoneCo Ltd is listed in the sector of the イタリア証券取引所 with ticker 1STNE. The last closing price for StoneCo was -. Over the last year, StoneCo shares have traded in a share price range of 8.356 € to 16.89 €.

StoneCo currently has 243,228,226 shares in issue. StoneCo has a price to earnings ratio (PE ratio) of 4.05.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	9.266	9.266	9.184	0	0	DE
4	0	0	8.826	10.09	8.356	573	8.91780107	DE
12	0	0	11.33	13.41	8.356	266	9.63187879	DE
26	0	0	13.24	15.135	8.356	150	10.20647979	DE
52	0	0	12.045	16.89	8.356	85	10.97608222	DE
156	0	0	11.56	16.89	8.356	75	10.97967277	DE
260	0	0	11.56	16.89	8.356	75	10.97967277	DE

1STNE - Frequently Asked Questions (FAQ)

What is the current StoneCo Ltd share price?

The current share price of StoneCo Ltd is 0.00 €

How many StoneCo Ltd shares are in issue?

StoneCo Ltd has 243,228,226 shares in issue

What is the 1 year trading range for StoneCo Ltd share price?

StoneCo Ltd has traded in the range of 8.356 € to 16.89 € during the past year

What is the PE ratio of StoneCo Ltd?

The price to earnings ratio of StoneCo Ltd is 4.05

What is the cash to sales ratio of StoneCo Ltd?

The cash to sales ratio of StoneCo Ltd is 0.99

What is the registered address of StoneCo Ltd?

The registered address for StoneCo Ltd is Harbour Place, George Town, Grand Cayman, KY1-1002

What is the StoneCo Ltd website address?

The website address for StoneCo Ltd is www.stoneco.com.br

Hi_Lo

This will trade forever as long as there is volume. Bidding here at rock bottom. This will never be a FINRA delete as long as there is volume.
NV SoS a new entity will scoop this up and finish the Sharp legend 🚀
Google Gemini

https://g.co/gemini/share/4e20adf2ce7

Gmenfan

Gmenfan 2分前

SkyLimit2022

SkyLimit2022 3分前

theorysuit,

Is the FDA “pumping” too by approving the new
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177686613 P2 combo trial to proceed? 🙄

“Authorization of a Phase 2 trial represents more than permission to continue development

Steady_T

Steady_T 4分前

Why would you drive a company in financial straights into bankruptcy by spending money to get licensed in a market that it can't support?

At the time the UK application was filed the approval decision was expected in a reasonable time and that would have allowed the company to obtain

WarMachine

WarMachine 4分前

If the deal sticks this time $SCO will at minimum double.

Gmenfan

Gmenfan 4分前

InfiniteHaven63

InfiniteHaven63 5分前

Happy Sunday to all my BLEG peeps!

RIGATONI

RIGATONI 6分前

~DTREF .09...

Reminder and this new article...

Again, China is behind this drop imo...

June 9th..

Gmenfan

Gmenfan 6分前

Oh dear................ :-)

joe botts

joe botts 8分前

Lol! Whew lunch and Applebee's for dinner money.

ddls

All this enthusiasm for a stock that trades 10 or less times a day. More posts than trades....hmmmmmmm!

joe botts

joe botts 10分前

No way what about Wertheim! Lmao

BIOChecker4

BIOChecker4 11分前

“CROs were responsible for the data and they are not combing through their work.“

You could not possibly know this. You are making a supposition that is not supported by any evidence.

As for no need to check every nook and cranny, the exact opposite is true. Every bit

luckydude777

luckydude777 14分前

Sure hope the "deal" is legit. Will be nice if it is.

BIOChecker4

BIOChecker4 16分前

Your logic is flawed. How would Dr. K. Know the AD data are good when the trials that generated the data were flawed? This is the reason large, well designed phase 3 trials are necessary and will be required by drug regulators.

theorysuit

theorysuit 16分前

Don't worry all the people posting on here are paid pumps. That's why they are apologizing and assigning blame to anyone but nwbo. No sane investor would be happy with this lying POS company who has failed in so many ways.

These small pumps for the company to offload thei

NYATC

Let hope they don’t “screw the pooch”. You know that one? 😆

AJH92

$ECOX Overview - Updated June 13, 2026

New CEO: Richard C Hawkins wef April 2, 2025

Reverse Merger With Kepler GTL

Letter of Intent to Combine [source: PR February 17, 2026]

- On February 12, 2026 entered into a non-binding Letter of Intent

ddls

This stock is finished, done, the end...but you go ahead and dream of something else.

HyGro

NWBO didn't have much choice. FDA took a pass, EU is more difficult, so UK looked like their best option.

The EU requires interaction with multiple bodies: EMA scientific assessment via rapporteurs, CHMP opinion, and then EC legal decision, plus subsequent national pricing/HTA negot

nwsun

Hopefully we all make a big gain on another investment and we can use sflm as a full write off against those gains.

theorysuit

theorysuit 21分前

Oh sure blame the mhra for it taking this long. Where are the other applications/submissions LP In promised 3 years ago. Do you want to blame that on MHRA too? Blame anyone else is their mantra .......lmfao. Is that why LP says they won't update on status? Protesting the rejection?Lmfao at

William777

William777 21分前

(Nutanomics) also known as NNI produced and branded its own product line, and began to sell to the retail outlets and to the public. NNI has also produced formulas for hundreds of other companies. Trademarks, Tradenames, and Patents: NNI®, NutraNomics®, HEC®, Health Education Corporation®, AES®, Ass

Vexari

Vexari 21分前

Brian's Song (1971)

This highly acclaimed winner of five Emmy Awards

It's the true story of a special relationship between two professional football players

Gale Sayers (Billy Dee Williams) and Bria

International bonds 3.12...

Invesco Markets II Plc I...

Societ Nat Sncf 0.875% b...

Walgreens Boots Alliance

Prime All Share Performa...

Alphamin Resources

iShares MSCI Brazil UCIT...

Hydrograph Clean Power

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。